Derivatives of dihydroxypyrrolidine as anti- cancer compounds
The present invention relates to derivatives of dihydroxypyrrolidine useful in the treatment of cancer. The invention further relates to a process for making the compounds. The compounds are inhibitors of alpha mannosidase, and possibly, also inhibit nicotinamide phosphoribosyl transferase.
- Search for this record at the European Patent Office
Record created on 2015-09-22, modified on 2016-08-09